Currently, it is in experimental stages and not yet approved for clinical use but shows exciting potential
Who should avoid these peptides Pregnant or breastfeeding women should avoid all therapeutic peptides due to insufficient safety data in these populations
Before acting on ghk-cu topical, compare realistic benefits, limitations, safety, and total cost before acting
Gastrointestinal effects lead: nausea, diarrhea, constipation, and vomiting, dose-dependent and clustered during escalation, mostly mild. Tirzepatide also produces a modest chronic heart-rate rise with a larger escalation-phase peak. Oral-contraceptive absorption can fall after starting and after each increase, so use backup or non-oral contraception for 4 weeks each time. What is known about concurrent metformin and tirzepatide use
Additionally, a post-hoc compiler average causal effect analysis was performed to estimate the influence of treatment adherence on outcomes